E

Ensysce Biosciences

9 employees

Ensysce Biosciences develops an abuse-deterrent and overdose technology that can be applied to 75% of all marketed drugs.

Basic info

Industry

biotechnology research

Sectors

prodrug

Biotechnology

Abuse Deterrent Technology

Oncology

Pharmaceutical

Drug Delivery

Single-Walled Carbon Nanotubes

Overdose Protection

Health Care

Pain

Opioids

Medical

Date founded

2008

Funding rounds raised

Total raised

$60M

from 5 investors over 5 rounds

E

Ensysce Biosciences raised $60M on January 1, 2021

Investors: GEM Management Limited

E

Ensysce Biosciences raised $15M on September 26, 2019

Investors: The National Institute on Drug Abuse (NIDA)

E

Ensysce Biosciences raised $9.3M on September 17, 2018

Investors: The National Institute on Drug Abuse (NIDA)

E

Ensysce Biosciences raised $1M on June 6, 2012

Investors: Texas Wide Open for Business

E

Ensysce Biosciences raised $1.5M on June 10, 2010